Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| 9825 | ETCTN | A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian Cancer | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9837 | ETCTN | Phase I Study of TRC102 in Combination with Cisplatin and Pemetrexed in Patients with Advanced Solid Tumors / Phase II Study of TRC102 with Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9844 | ETCTN | A Phase 1 Study Evaluating Safety; Tolerability; and Preliminary Antitumor Activity of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9846 | ETCTN | Patient-Derived Models Tissue Procurement Protocol For The National Cancer Institute (NCI) | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9853 | ETCTN | A Phase 1 Study of AZD1775 in Combination with Belinostat in Relapsed and Refractory Myeloid Malignancies and Selected Untreated Patients with Acute Myeloid Leukemia | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9855 | ETCTN | A Phase 2 Study of CDX-011 (glembatumumab vedotin) for Metastatic Uveal Melanoma | Adult CIRB - Early Phase Emphasis | Completed | |
| 9874 | ETCTN | A Phase I Trial of AT13387 in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) receiving Concurrent Radiation and Cisplatin | Adult CIRB - Early Phase Emphasis | Completed | |
| 9875 | ETCTN | Phase 2 Study of AT13387 (onalespib) in ALK+ ALCL; MCL; and BCL-6+ DLBCL | Adult CIRB - Early Phase Emphasis | Completed | |
| 9876 | ETCTN | Phase 1b Study of HSP90 Inhibitor, AT13387 (onalespib) in Combination with Paclitaxel in Patients with Advanced, Triple Negative Breast Cancer. | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 9878 | ETCTN | A Phase 1/2 Trial of Erlotinib and Onalespib lactate in EGFR-Mutant Non-Small Cell Lung Cancer | Adult CIRB - Early Phase Emphasis | Completed |